About Navamedic
Navamedic is a publicly listed company based in Lysaker (Norway) founded in 2004. Traditional company manufacturing and marketing a range of pharmaceutical formulation products. Navamedic has completed 1 acquisition, including Impolin. Its chief executive, as recorded, is Kathrine Gamborg Andreassen. Its website navamedic.com draws about 13 thousand monthly visits. Navamedic offers products and services including Eroxon, Medical Nutrition Products, and Antibiotics. Its focus areas include Diversified Pharmaceuticals. Its legal entity is Navamedic ASA.
Company details
Navamedic was founded in 2004 and is based in Lysaker, Norway. Operations focus on the manufacturing and marketing of pharmaceutical formulation products within the healthcare sector. Business areas encompass pharmaceuticals, nutrition products, and consumer care items. Product groups cover female care, medical nutrition, oral medicine, urology, dermatology, tenderhospital supplies, rheumatology, oncology, cardiology, antibiotics, immunology, neurology, gastrointestinal, and endocrinology treatments.
- Headquarters Lysaker, Norway
- Stage Public
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Website navamedic.com
- Social LinkedIn YouTube
- Legal Name Navamedic Asa
- Annual Revenue$56.09 M (USD)6.38as on Dec 31, 2025
- Net Profit-$2.34 M (USD)-329.13as on Dec 31, 2025
- EBITDA$4.34 M (USD)-6as on Dec 31, 2025
- Investors
- Investments & Acquisitions
Products & Services of Navamedic
Navamedic offers a comprehensive portfolio of products and services, including Eroxon, Medical Nutrition Products, and Antibiotics.
Clinically proven treatment for erectile dysfunction in men.
Specialized products for metabolic disorders like Phenylketonuria.
Medications for bacterial infections and related health needs.
Apps and channels of Navamedic
its YouTube channel Navamedic Norge has 39 subscribers and 30 videos.
Videos from Navamedic
The most watched videos on Navamedic's YouTube channel, Navamedic Norge (39 subscribers). Click a video to play it here.
More on Navamedic Norge.
Funding Insights of Navamedic
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Navamedic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | Private Equity Round | – | Reiten & Co | – |
1 investors in total: 1 institutional.
Investors in Navamedic
Navamedic has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Reiten & Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Reiten & Co is engaged in private equity investments. | 1996 | reitenco.com | Oslo, Norway |
Investor details for Navamedic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Navamedic
11 people are tracked at Navamedic (7 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Kathrine Gamborg Andreassen | CEO | Leadership |
Philip Slätis | Commercial Director, Head Of Rx And International | Leadership |
Lars Hjarrand | Chief Financial Officer | Leadership |
Astrid T. Bratvedt | Chief Scientific Officer | Leadership |
Alexander Lidmejer | Chief Operations Officer | Leadership |
Krister Sagulin | Country Manager | Head Of Business Unit Finland, Director Regional Sales & Process Development | Leadership |
Ole Henrik Eriksen | Chief Business Development Officer | Leadership |
Ida Juell | Scandinavian Product Manager Neurology | Team |
Åsa Renhult | Nordic Marketing Manager (rx) | Team |
Camilla Modorato | Quality Assurance Manager | Team |
Jonathan Svensson | Purchase And Logistics Manager | Team |
Complete people profiles for Navamedic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Navamedic
Navamedic is a publicly listed company on the OSL with ticker symbol NAVA in Norway, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Mar 2006
- Listed onOSL: NAVA
- Listed entityNavamedic ASA
- Exchange sectorDistribution services
- ISINNO0010205966
- Share price13.00 NOK · 2026-10-14
- Market capitalisation311,757,921.00 NOK
- EPS (diluted, trailing year)-0.97 NOK
- Volume (last session)90
Financials of Navamedic
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 565.4M NOK | -23.5M NOK | 43.8M NOK |
| 2024 | 531.4M NOK | -5.5M NOK | 46.5M NOK |
| 2023 | 512.0M NOK | -13.7M NOK | 35.5M NOK |
| 2022 | 382.1M NOK | 29.4M NOK | 51.7M NOK |
| 2021 | 278.4M NOK | 618,000 NOK | 18.2M NOK |
Detailed financial statements for Navamedic
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Navamedic
Navamedic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Impolin.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diversified drugs are distributed by Impolin in Sweden. | impolin.se | Taby, Sweden | 2004 | May 2022 | •••• |
Complete acquisition details for Navamedic
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Navamedic
4 dated milestones of Navamedic across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Navamedic is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
- Acquisition Acquires Impolin.
Web traffic of Navamedic
The website of Navamedic (navamedic.com) receives about 12.9K visits a month and ranks #3,740,020 among all websites worldwide, #4,091 in Pharmacy.
- Monthly visits12.9K
▲ 109.6% vs previous month
- Unique visitors2.8K
per month
- Global rank#3,740,020
among all websites
- Category rank#4,091
Health · Pharmacy
- Bounce rate35%
- Pages per visit1.1
- DevicesDesktop 13% · Mobile 87%
Websites whose visitors overlap most with Navamedic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gabionline.net | 100% | #1,546,519 | View details | ||
us.sandoz.com | us.sandoz.com | 100% | – | ||
memidis.nl | memidis.nl | 100% | #4,778,706 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Navamedic
Complete news archive for Navamedic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navamedic
Navamedic was founded in 2004 and raised its 1st funding round 14 years after it was founded.
Navamedic is headquartered in Lysaker, Norway.
Kathrine Gamborg Andreassen is the CEO of Navamedic, as recorded in our data.
Annual revenue of Navamedic is $56.09M as on Dec 31, 2025.
Navamedic was founded in 2004 and is based in Lysaker, Norway. Operations focus on the manufacturing and marketing of pharmaceutical formulation products within the healthcare sector. Business areas encompass pharmaceuticals, nutrition products, and consumer care items. Product groups cover female care, medical nutrition, oral medicine, urology, dermatology, tenderhospital supplies, rheumatology, oncology, cardiology, antibiotics, immunology, neurology, gastrointestinal, and endocrinology treatments.
Navamedic offers Eroxon, Medical Nutrition Products, and Antibiotics.
Yes, Navamedic is publicly traded on OSL under the ticker symbol NAVA.
Navamedic has made 1 acquisition, including Impolin.
Navamedic has 1 investor. Key investors include Reiten & Co.
Navamedic operates through Navamedic Asa.